Medical, Scientific and Technology Advisory Board

Dr. Rick Barnett is a clinical psychologist who is an expert in addictive disorders (including sex, drugs and food addiction) and problems such as depression, anxiety, and relationship difficulties. Dr. Barnett has experience in a range of approaches to treating problems related to addictive behaviors.

Dr. Danielle Wise has 30 years of experience in psychotherapy, mental health coaching, and therapy work with thousands of clients with significant experience in psychedelic aftercare and utilizing telemedicine tools in her practice.

Dr. Gary Wynn is Professor of Psychiatry and Neuroscience, Assistant Chair of the Department of Psychiatry, and Senior Scientist at the Center for the Study of Traumatic Stress. He is also a Distinguished Fellow of the American Psychiatric Association and on the Journal of Neuroscience Research's editorial board. Dr. Wynn received his education at the United States Military Academy at West Point and Uniformed Services University of the Health Science.

Dr. Denton Hoyer has been involved in drug discovery at leading pharmaceutical companies and research institutions for the last 30 years. He holds numerous patents and has been published extensively in the field of medicinal chemistry and drug research. Dr. Hoyer has unparalleled expertise in computational chemistry-enabled probe molecule design, drug design and optimization, synthetic planning and execution, evaluation of chemical novelty, and intellectual property.

Dr. Robin Carhart-Harris leads Imperial College London’s Centre For Psychedelic Research. He regularly publishes research on psychedelic medicines from clinical perspectives.

As the Director of The University of Adelaide's Centre for Traumatic Stress Studies, Professor Sandy McFarlane's area of particular specialty has been the effects of traumatic stress and is an international expert in the impact of disasters post-traumatic stress disorder (PTSD). His research has focused on the epidemiology and longitudinal course of PTSD and the neuroimaging of the cognitive deficits in this disorder. He has published over 250 articles and chapters in various refereed journals and has co-edited three books.

Dr. Eric Vermetten is a professor of Medical-Biological and Psychiatric Aspects of Psychotrauma, LUMC/ University of Leiden. The chair was established by Arq Psychotrauma Research and the Dutch Ministry of Defense. Eric Vermetten is an active clinical psychiatrist at the MGGZ in Utrecht (Military Mental Health care).

Dr. Zul Meraly was President/CEO and Scientific Director of the University of Ottawa Institute of Mental Health Research. He was also a full professor in the faculties of Medicine (Departments of Cellular and Molecular Medicine and Psychiatry) and Social Sciences (Psychology) at the University of Ottawa, as well as a research professor at the Institute of Neuroscience at Carleton University.

Dr. Ruth Lanius is a professor of psychiatry and is the director of the post-traumatic stress disorder (PTSD) research unit at Western University. Established the Traumatic Stress Service and the Traumatic Stress Service Workplace Program, services that specialize in the treatment and research of PTSD.

Dr. Frewen joined the departments of psychiatry and psychology at the University of Western Ontario in London, Ontario, Canada in September 2008. He completed his doctorate in clinical psychology at Western and his post-doctoral residency at the Royal Ottawa Mental Health Centre.

Dr. Vince Politio is a cognitive science researcher at Macquarie University, Australia with significant experience in psilocybin microdosing research. In 2019, he led and conducted one of the largest to date, systematic studies of microdosing psychedelics.

Dr. David Erritzoe is the NIHR Academic Clinical Lecturer in general psychiatry at the Neuropsychopharmacology and Psychedelic Research Centres in the Division of Psychiatry, Department of Brain Sciences at Imperial College London.

Anton Gomez-Escolar is a psychopharmacologist, a member of the UNAD commission on international drug policy. He is also an advisor to large pharma and nutraceutical companies, investment firms, and government committees on public health.

Dr. John Bradley is a retired U.S. Army Psychiatrist and combat veteran with 26 years on Active Duty before joining the VA Boston Healthcare System in 2011. He is board-certified in psychiatry and has focused his career on suicide prevention and combat trauma.

Dr. Carl Castro is the research director for the USC Center for Innovation and Research on Veterans and Military Families. Dr. Castro has served in a variety of research and leadership positions, including commander of the U.S. Army Medical Research Unit- Europe in Heidelberg, Germany; chief of the Department of Military Psychiatry at the Walter Reed Army Institute of Research in Washington, D.C.; and director of the Military Operational Medicine Research Program, headquarters, U.S. Army Medical Research and Materiel Command, Fort Detrick, MD. 

Castro has authored more than 150 scientific articles and reports in numerous research areas and currently serves as chair of a NATO research group on military mental health training. He serves as an advisor for several Department of Defense research panels focused on psychological health.

Dr. Shawn Rhind is a senior Defense Scientist in the military Operational Health and Performance section at Defence Research and Development Canada (DRDC) and an Associate Professor at the University of Toronto. He leads an integrative – molecular to systemic – translational research team investigating the immunoregulatory mechanisms of (psycho)physiological stress and trauma-associated changes in cellular and humoral immune and inflammatory responses.